Rein Therapeutics Inc. (RNTX)
NASDAQ · Healthcare
Rein Therapeutics Inc. EPS 2015–2025
Rein Therapeutics Inc. annual/quarterly eps history and growth rate from 2021 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Rein Therapeutics Inc. eps for the quarter ending March 31, 2026 was $0.19, a 24.00% decrease year-over-year.
- Rein Therapeutics Inc. annual eps for 2025 was $1.96, a 44.16% decrease from 2024.
- Rein Therapeutics Inc. annual eps for 2024 was $3.51, a 2.63% increase from 2023.
- Rein Therapeutics Inc. annual eps for 2023 was $3.42, a 43.19% decrease from 2022.
- Rein Therapeutics Inc. annual eps for 2022 was $6.02.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Rein Therapeutics Inc. EPS — FAQ
Rein Therapeutics Inc. (RNTX) eps over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
What is Rein Therapeutics Inc.'s eps?
Rein Therapeutics Inc. (RNTX) reported eps of $-1.96 for fiscal 2025.
Where can I see RNTX's eps history?
The chart and table above show Rein Therapeutics Inc.'s eps by year and by quarter, including the growth rate.